Rashid Girshab, MD
Family Practice · Utica, NYNPI 1497014674
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Pfizer at 36.6% of the total. Reporting peaked in 2019 at $397 and has fallen 95.7% since, to $17 in 2025. Among family practice clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$337
- CSL Behring$154
- Boehringer Ingelheim$124
- Merck$85
- E.r. Squibb & Sons, L.L.C.$61
- Otsuka America Pharmaceutical, Inc.$58
- plus $105 from 5 others
What the payments were for
- Food & beverage$923100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 18 | $337 |
| CSL Behring | 6 | $154 |
| Boehringer Ingelheim | 7 | $124 |
| Merck | 5 | $85 |
| E.r. Squibb & Sons, L.L.C. | 4 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| AbbVie | 2 | $29 |
| Philips North America LLC | 1 | $22 |
| Gilead | 1 | $20 |
| Vapotherm Inc | 1 | $18 |
| UCB, Inc. | 1 | $16 |
How this compares
$923 in reported general payments places this provider in the 95th percentile of 792 family practice providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 12 | $818 |
| Cefpodoxime Proxetil | 23 | $664 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $118 |
| Prednisone | 17 | $67 |
| Amlodipine Besylate | 14 | $42 |
Paid to pharmacies, not to this prescriber.
Other family practice in Utica
- Benjamin WuBrooklyn$16K
- Carmen FamiliaBronx$11K
- Rosanne CebelenskiDeer Park$10K
- Sumathy ReddyIsland Park$4K
- Yagnasri EagalaNew Hartford$2K
- Kristen MerolaSyracuse$1K
- Kristen MailandEast Setauket$934
- Esra Bayram FidanRiverhead$888
- Deborah CohenJohnson City$770
- Michael RaghunathOceanside$607
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.